Targeted Therapies in Lung Cancer Patient Forum 2017 – It’s a Wrap!

dbrock's picture
Denise Brock, Operations Director

On Saturday, September 16, 2017, patients, caregivers, family members and friends joined GRACE in Cleveland at the Taussig Cancer Center for a full day of discussion on Targeted Therapies in Lung Cancer.  We are thrilled that people joined us for this amazing and informative day.  Huge thanks to all of the faculty who spent their Saturday in Cleveland with our community, and thanks also to those organizations who sponsored this event - Astra Zeneca, Takeda, Boehringer Ingelheim, Ignyta, Novartis, Genentech, Caris, and Guardant Health.  

 

We started the day out with a warm welcome from our Forum Chair - Dr. Nathan Pennell.  For the full agenda, faculty list, presentations, and videos from the webcast, please visit the 'webcast details' page, available via this link.     

  

 

 

 

 

 

 

 

 


 

 

 

 

 

The morning sessions continued:

The Many Faces of Progression
 Dr. Nathan Pennell, Cleveland Clinic Cancer Center

The Role of Local Therapy

 Dr. Shirish Gadgeel, Michigan Medicine, University of Michigan

 Biopsies & Re-biopsies
 Dr. Karen Reckamp, City of Hope Comprehensive Cancer Center 

The Question of Clinical Trials

 Dr. Alice Shaw, Massachusetts General Hospital

 The Crossroads:

 Local Therapy, Chemo, Targeted  Therapy, or Immunotherapy?

 Panel Discussion with Drs. Pennell,  Gadgeel, Reckamp, and Shaw, and patients John Cherol (EGFR), Matt  Hiznay (ALK), and Sara Whitlock (RET). Moderator: Dr. H. (Jack) West 

 

 
 
 
 

Lunch was an opportunity to have further discussion with the faculty.  Cleveland Clinic Cancer Center graciously allowed us to set up lunch on the 1st floor in their beautiful new facility.


 
 
 

After lunch the breakout discussions continued: 

 

ALK/ROS1

 Dr. Alice Shaw, Dr. Shirish Gadgeel, and Matt Hiznay, ALK patient

 EGFR

 Dr. Nathan Pennell, Dr. H. (Jack) West, and John Cherol, EGFR patient

 MET/RET/BRAF

 Dr. Karen Reckamp, Dr. Vamsidhar  Velcheti, and Sara Whitlock, RET patient 

 

The day concluded with the afternoon general session: 

Managing the Cost of Cancer Care
 Dr. James P. Stevenson, Cleveland Clinic Cancer Center

 Patient to Patient Mentoring
 Kathryn Sefcek, MHA, 4th Angel Mentoring Program

 Caveat Emptor: Assessing Cancer Information from Sources of  Varying Quality  
 Dr. H. (Jack) West, Swedish Cancer Institute & Founder of  cancerGRACE, and Janet Freeman-Daily, ROS1 patient,  #LCSM Twitter Chat co- moderator, Cure  Today contributor, blogger

 

Please click here to visit the Targeted Therapies in Lung Cancer Webcast page for viewing the videos in full!  (Please note, we will be editing the videos to cut them down - they are in raw format at this time).

 

 

Please feel free to offer comments and raise questions in our Discussion Forums.


GRACE would like to thank the following sponsors for their support of this program

 

 

Join the Conversation

Please feel free to offer comments and raise questions in our
discussion forums.

 Join The conversation